Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter?
HTML
Details
Locations
Year:
2019
Type:
review
Source:
Current Hematologic Malignancy Reports
DOI:
10.1007/s11899-019-0497-7
Authors:
Shalin Kothari,
Jens Hillengass,
Philip L. McCarthy,
Sarah A. Holstein
Institutions:
Roswell Park Comprehensive Cancer Center,
University of Nebraska Medical Center
Language:
English
Topic:
Multiple Myeloma Research and Treatments
Subfield:
Hematology
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
Funders:
Bristol-Myers Squibb,
GlaxoSmithKline,
Academy of Finland
OpenAlex ID:
W2918534205
FWCI:
0.16
Cites:
52
Cited by:
9
Related to:
10